Latest RNS Announcements

January 09, 2023

Appointment of Independent Non-Executive Director


December 22, 2022

Contract Extension with Leading CRO


November 30, 2022

Holding(s) in Company


October 12, 2022

Exercise of Options, Issue of Equity and Total Voting Rights


September 27, 2022

Half Year Report


September 27, 2022

Settlement of Historical Contractual Licence Dispute


September 13, 2022

Notice of Results and Investor Presentation


September 09, 2022

Holding(s) in Company


September 02, 2022

$12m five-year agreement with Leading Contract Research Organisation


August 04, 2022

Half Year Trading Update


June 29, 2022

Holding(s) in Company


June 09, 2022

Result of AGM


May 20, 2022

Holding(s) in Company


May 17, 2022

Notice of AGM & Posting of Annual Report


May 03, 2022

Holding(s) in Company


May 03, 2022

European Medicines Agency Research Grant


April 26, 2022

Unaudited Results for the Year Ended 31 December 2021 & Investor Presentation


April 26, 2022

Earn Outs and Deferred Payments


March 15, 2022

Grant of PDMR Options


March 14, 2022

Exercise of Options, Issue of Equity and Total Voting Rights


March 14, 2022

Holding(s) in Company


February 21, 2022

Holding(s) in Company


February 04, 2022

Exercise of Options, PDMR Dealing, Issue of Equity and Total Voting Rights


January 26, 2022

Trading Update


January 11, 2022

Appointment of Stifel as Joint Broker


December 21, 2021

H2 China Market Update


December 13, 2021

Holding(s) in Company


November 25, 2021

Holding(s) in Company


November 22, 2021

New In Silico Software Release


November 22, 2021

Holding(s) in Company


October 11, 2021

Director/PDMR Dealings


September 29, 2021

Holding(s) in Company


September 29, 2021

Appointment of Independent Non-Executive Director


September 28, 2021

Grant of PDMR Options


September 27, 2021

Half Year Report


September 14, 2021

Notice of Results and Investor Presentation


September 14, 2021

Exercise of Options, Issue of Equity and Total Voting Rights


September 01, 2021

Earnings Enhancing Acquisition of PDS Pathology Data Systems


July 19, 2021

Half Year Trading Update


June 16, 2021

Holding(s) in Company


June 14, 2021

Notice of Capital Markets Day


May 27, 2021

Result of AGM


May 11, 2021

Holding(s) in Company


May 06, 2021

Holding(s) in Company


April 20, 2021

Exercise of Options, Issue of Equity and Total Voting Rights


April 19, 2021

Grant of Options


April 19, 2021

Notification of Major Holdings


April 15, 2021

Notification of Major Holdings


April 12, 2021

Audited Results for the Year Ended 31 December 2020 & Investor Presentation


April 01, 2021

Completion of Acquisition of d-wise, Issue of Equity and Total Voting Rights


March 31, 2021

Notice of Results


March 22, 2021

Earnings Enhancing Acquisition of d-wise and Investor Presentation


March 01, 2021

Earnings Enhancing Acquisition of The Edge


January 14, 2021

Trading Update